Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 62,756 | 32,608 | 29,766 | -239,679 | 32,657 |
| Operating Income | -62,756 | -32,608 | -29,766 | 239,679 | -32,657 |
| Other Income | 4,615 | 3,662 | 2,353 | 456 | 197 |
| Pre-tax Income | -58,141 | -28,946 | -27,413 | 240,135 | -32,460 |
| Income Tax | N/A | -1,858 | -2,523 | 66,070 | -19,568 |
| Net Income Continuous | -58,141 | -27,088 | -24,890 | 174,065 | -12,892 |
| Minority Interests | -179 | -306 | -86 | -833 | -794 |
| Net Income | $-57,962 | $-26,782 | $-24,804 | $174,898 | $-12,098 |
| EPS Basic Total Ops | -1.42 | -0.63 | -0.54 | 3.90 | -0.27 |
| EPS Basic Continuous Ops | -1.43 | -0.63 | -0.55 | 3.88 | -0.29 |
| EPS Diluted Total Ops | -1.42 | -0.58 | -0.54 | 3.77 | -0.27 |
| EPS Diluted Continuous Ops | -1.43 | -0.58 | -0.55 | 3.75 | -0.29 |
| EBITDA(a) | $-62,684 | $-32,549 | $-29,757 | $239,691 | $-32,644 |